Norco and Lymphadenopathy mediastinal - a phase IV clinical study of FDA data

Summary:

Lymphadenopathy mediastinal is reported as a side effect among people who take Norco (acetaminophen; hydrocodone bitartrate), especially for people who are male, 50-59 old, also take Zometa, and have Breakthrough pain.

The phase IV clinical study analyzes which people have Lymphadenopathy mediastinal when taking Norco. It is created by eHealthMe based on reports of 71,619 people who have side effects when taking Norco from the FDA, and is updated regularly.

What is Norco?

Norco has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 74,063 Norco users. Check the latest studies of Norco.

What is Lymphadenopathy mediastinal?

Lymphadenopathy mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs) is found to be associated with 516 drugs and 480 conditions by eHealthMe. Check the latest studies of Lymphadenopathy mediastinal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

71,619 people reported to have side effects when taking Norco.
Among them, 19 people (0.03%) have Lymphadenopathy mediastinal.

Could Norco cause Lymphadenopathy mediastinal?

Among these 19 people:

What is the gender of people who have Lymphadenopathy mediastinal when taking Norco? *

  • female: 26.32 %
  • male: 73.68 %

What is the age of people who have Lymphadenopathy mediastinal when taking Norco? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 5.88 %
  • 50-59: 82.35 %
  • 60+: 11.76 %

What are other drugs people take besides Norco? *

  1. Zometa: 13 people, 68.42%
  2. Coreg: 11 people, 57.89%
  3. Zocor: 11 people, 57.89%
  4. Florinef: 11 people, 57.89%
  5. Plavix: 11 people, 57.89%
  6. Vasotec: 11 people, 57.89%
  7. Enalapril Maleate: 10 people, 52.63%
  8. Prednisone: 7 people, 36.84%
  9. Ms Contin: 4 people, 21.05%
  10. Dilaudid: 3 people, 15.79%

What are other side effects people have besides Lymphadenopathy mediastinal? *

  1. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 15 people, 78.95%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 15 people, 78.95%
  3. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 14 people, 73.68%
  4. Joint Pain: 14 people, 73.68%
  5. Weakness: 14 people, 73.68%
  6. Stress And Anxiety: 14 people, 73.68%
  7. Infection: 13 people, 68.42%
  8. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 13 people, 68.42%
  9. Deformity (disfigurement): 13 people, 68.42%
  10. Injury: 13 people, 68.42%

What are the existing conditions these people have? *

  1. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 10.53%
  2. Stress And Anxiety: 2 people, 10.53%
  3. Breakthrough Pain: 2 people, 10.53%
  4. Bipolar Disorder (mood disorder): 1 person, 5.26%
  5. Breast Cancer Metastatic: 1 person, 5.26%
  6. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 5.26%
  7. Diabetes: 1 person, 5.26%
  8. Diarrhea: 1 person, 5.26%
  9. Dyspnea (difficult or laboured breathing): 1 person, 5.26%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Norco and have Lymphadenopathy mediastinal?

- Check whether Lymphadenopathy mediastinal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Norco:

Lymphadenopathy mediastinal treatments and more:

How severe was Lymphadenopathy mediastinal and when was it recovered:

Expand to all the drugs that have ingredients of acetaminophen; hydrocodone bitartrate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Norco:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lymphadenopathy mediastinal:

Browse all the conditions that are associated with Lymphadenopathy mediastinal:


How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate (the active ingredients of Norco) and Norco (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: